Company / Gross Margin
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Gross Margin History
FY2016-FY2018 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Margin
31.9%
FY2018
5-year range
-
FY2016-FY2018
Trend
-13.9%
vs FY2017
Sector context
#79 of 96
Health Care
What the data says
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.'s gross margin of 31.9% is lower than 82% of companies in the Health Care sector (FY2018). Declined from 48.7% to 31.9% over the past 2 years.
Based on SEC 10-K filings.
31.9% in FY2018.
Declined from 48.7% to 31.9% over the past 2 years.
Health Care sector context is included.
Gross Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
Bottom 18% in Health CareTop 82% of 96This company 31.9% Sector average 53.6%
▼
-40.4% below sector average
Key checks
Key Insights
- In FY2018, gross margin decreased 13.9% year-over-year.
- Currently 21.7pp below the Health Care sector average.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -1.92 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | 31.9% | -13.9% |
| FY2017 | 37.1% | -23.8% |
| FY2016 | 48.7% | +113.7% |
As of FY2018 · SEC 10-K · Updated Jun 30, 2026